Skip to main content
. 2020 Feb 11;38(7):1753–1761. doi: 10.1016/j.vaccine.2019.12.034

Table 1.

Demographic characteristics of study participants.

Characteristics Boosted immunized group Primary immunized group Total p-value
Overall n = 121 n = 119 n = 240
Gender Male (%) 60 (49.59) 47 (39.50) 107 (44.58) 0.116
Female (%) 61 (50.41) 72 (60.50) 133 (55.42)
Age (years) Mean (SD) 21.24 (16.95) 20.23 (15.73) 20.74 (16.33) 0.633
Median (min, max) 18.41 (4.16, 84.42) 17.40 (4.27, 80.04) 17.80 (4.16, 84.42)



Adult cohort n = 61 n = 59 n = 120
Gender Male (%) 28 (45.90) 18 (30.51) 46 (38.33) 0.083
Female (%) 33 (54.10) 41 (69.49) 74 (61.67)
Age (years) Mean (SD) 35.58 (12.08) 33.94 (10.65) 34.78 (11.38) 0.433
Median (min, max) 33.29 (18.41, 84.42) 31.73 (18.20, 80.04) 32.28 (18.20, 84.42)



Older Children cohort n = 30 n = 30 n = 60
Gender Male (%) 16 (53.33) 17 (56.67) 33 (55.00) 0.795
Female (%) 14 (46.67) 13 (43.33) 27 (45.00)
Age (years) Mean (SD) 8.62 (2.67) 8.81 (3.53) 8.71 (3.11) 0.820
Median (min, max) 7.99 (5.08, 14.19) 8.21 (5.03, 17.40) 8.10 (5.03, 17.40)



Young Children cohort n = 30 n = 30 n = 60
Gender Male (%) 16 (53.33) 12 (40.00) 28 (46.67) 0.301
Female (%) 14 (46.67) 18 (60.00) 32 (53.33)
Age (years) Mean (SD) 4.70 (0.22) 4.69 (0.19) 4.70 (0.20) 0.869
Median (min, max) 4.74 (4.16, 4.99) 4.74 (4.27, 4.99) 4.74 (4.16, 4.99)